Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (3y) (2016 - 2026)
Armata Pharmaceuticals (ARMP) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Armata Pharmaceuticals |
275.44 Mn |
270.68 Mn |
- |
-36.08% |
| Date | Value |
|---|
| Mar 31, 2026 |
-36.08% |
| Dec 31, 2025 |
16.78% |
| Sep 30, 2025 |
42.59% |
| Jun 30, 2025 |
7.93% |
| Mar 31, 2025 |
-61.64% |
| Dec 31, 2024 |
-63.74% |
| Sep 30, 2024 |
-19.27% |
| Jun 30, 2024 |
-32.55% |
| Mar 31, 2024 |
23.46% |
| Dec 31, 2023 |
-19.11% |
| Sep 30, 2023 |
70.71% |
| Jun 30, 2023 |
-49.01% |
| Mar 31, 2023 |
-17.87% |
| Dec 31, 2022 |
-58.25% |
| Sep 30, 2022 |
-37.08% |
| Jun 30, 2022 |
-49.50% |
| Mar 31, 2022 |
137.24% |
| Dec 31, 2021 |
-40.24% |
| Sep 30, 2021 |
-38.06% |
| Jun 30, 2021 |
-33.23% |
